moxonidine has been researched along with Albuminuria in 3 studies
moxonidine: structure given in first source
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
Excerpt | Relevance | Reference |
---|---|---|
" The aim of this study was to evaluate the effect of a new antihypertensive agent, moxonidine (M), on microalbuminuria (urine albumin excretion, UAE), plasma thrombomodulin (TM), and tissue plasminogen activator inhibitor (PAI-1) in patients with mild to moderate EH associated with increased UAE." | 9.08 | Moxonidine effect on microalbuminuria, thrombomodulin, and plasminogen activator inhibitor-1 levels in patients with essential hypertension. ( Hatzizacharias, AN; Krespi, PG; Kyriaki, D; Kyriakidis, M; Makris, TK; Triposkiadis, P; Tsoukala, C; Votteas, V, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krespi, PG | 1 |
Makris, TK | 1 |
Hatzizacharias, AN | 1 |
Triposkiadis, P | 1 |
Tsoukala, C | 1 |
Kyriaki, D | 1 |
Votteas, V | 1 |
Kyriakidis, M | 1 |
Amann, K | 1 |
Rump, LC | 1 |
Simonaviciene, A | 1 |
Oberhauser, V | 1 |
Wessels, S | 1 |
Orth, SR | 1 |
Gross, ML | 1 |
Koch, A | 1 |
Bielenberg, GW | 1 |
VAN Kats, JP | 1 |
Ehmke, H | 1 |
Mall, G | 1 |
Ritz, E | 2 |
Strojek, K | 1 |
Grzeszczak, W | 1 |
Górska, J | 1 |
Leschinger, MI | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System[NCT03109795] | Phase 4 | 30 participants (Actual) | Interventional | 2017-04-10 | Terminated (stopped due to Funding ended) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for moxonidine and Albuminuria
Article | Year |
---|---|
Moxonidine effect on microalbuminuria, thrombomodulin, and plasminogen activator inhibitor-1 levels in patients with essential hypertension.
Topics: Albuminuria; Antihypertensive Agents; Female; Humans; Imidazoles; Male; Middle Aged; Plasminogen Act | 1998 |
Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy?
Topics: Adult; Albuminuria; Animals; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic | 2001 |
1 other study available for moxonidine and Albuminuria
Article | Year |
---|---|
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.
Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Glomerulosclerosis, Focal Segmental; | 2000 |